Information updates

Novalac Allergy infant formula supply update

30 April 2019

Bayer Australia Ltd (Bayer) has advised ASCIA that Novalac Allergy formula is currently out of stock and ongoing stock shortages will continue over the coming months.  Please note that other Novalac products are unsuitable for infants diagnosed with cow’s milk protein allergy (CMPA).  Information on alternative formulas for infants with CMPA is on the ASCIA website: 

GPs, allergy and paediatric specialists can contact the Bayer Medical Information Team on behalf of patients to discuss compassionate/critical medical cases on 1800 008 757 or by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.

Bayer continues to work as a priority with the global manufacturing partner to increase supply of Novalac Allergy and an update on stock availability will be provided in June.

pdfNovalac Allergy Infant Formula Supply Update April 2019

 Novalac Allergy HCP Supply Update April 2019

Content created 30 April 2019

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.